HoN. F. H.: Particulate Matter in Parenteral Solutions I, A Review of the Literature, Drug Intelligence1: 7–11 (Jan.) 1967.
2.
GrossM. A.: The Danger of Particulate Matter in Solutions for Intravenous Use, Drug Intelligence1: 12–13 (Jan.) 1967.
3.
Anon: Selected Annotated References to Particulate Matter in Parenteral Solutions, Drug Intelligence1: 21–25 (Jan.) 1967.
4.
Proceedings, National Symposium on Safety of Large Volume Parenteral Solutions, Food and Drug Administration, U. S. Department of Health, Education and Welfare, Wash-D. C., July 28-29, 1966.
5.
GrovesM. J., and MajorJ. F.: Assessment of Particulate Matter in Normal Saline for Injection B. P. by Means of the Coulter Counter, Pharm. J.193: 227–228 (Sept. 12) 1964.
6.
VesseyI., and KendallC. E.: Determination of Particulate Matter in Intravenous Solutions, Analyst91: 273–279 (April) 1966.
7.
GrovesM. J.: Some Size Distributions of Particulate Contamination Found in Commercially Available Intravenous Solutions, J. Pharm. Pharmacol.18: 161–167 (March) 1966.
8.
KruytH. R., “Colloid Science,” Vol. I. Elsevier Publishing Co., Amsterdam, The Netherlands, 1952, Chapt. 7.
